Clinical Trial Update: Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Toripalimab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal Involvement [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a neoadjuvant regimen combining radiotherapy with toripalimab, liposomal irinotecan, and capecitabine for mismatch repair-prof…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma
• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Onivyde (liposomal irinotecan) (liposomal irinotecan)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Affiliated Cancer Hospital of Shantou University Medical College | Conditions: Rectal Cancer | Phase 1 | Status: RECRUITING